Jiangsu Medphoenix Medical Technology signs a cooperation agreement with Atuka Inc. [Photo/Taizhou Medical High-tech Zone via WeChat account weigg6666]
Jiangsu Medphoenix Medical Technology, located in the Taizhou Medical High-tech Zone in Taizhou city, East China's Jiangsu province, recently signed a milestone agreement with Canadian business Atuka Inc, marking its entry into the international market.
Leveraging Medphoenix's expertise in high-end medical equipment and surgical technology and Atuka's experience in neurodegenerative disease research, the cooperation between the two is expected to advance research and development into related disease treatment methods.
They will also share resources, optimize research processes and improve research efficiency, aiming to contribute to the development of the global biopharmaceutical industry.
Medphoenix is committed to building an innovative one-stop service platform for medical devices, providing businesses with comprehensive medical device listing solutions including medical research, animal testing, clinical trials, registration and certification.
Relying on top-flight surgical techniques and first-class medical equipment, it recently has assisted multiple European and American medical device companies in completing preclinical animal testing evaluations.
Atuka specializes in promoting the application of innovative therapies in the field of neurological diseases, with offices and facilities in Toronto and Suzhou city in Jiangsu province.
Over the past 20 years, Atuka has focused on providing preclinical evaluations for various neurological diseases for enterprises, helping to develop over 300 innovative therapies for over 90 companies worldwide.